Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:G

Genpact Ltd (G)

37.14
+0.21 (0.57%)
as of Aug 21, 2026, 8:00:00 pm Market Open.
1 watching
0
Investor Insights
star iconAug 22, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Genpact Ltd (G-N) has been a strong performer historically, having achieved earnings growth of 13% over the past 15 years. However, it has recently faced a downturn, losing about 20% this year amid concerns surrounding artificial intelligence, which some analysts believe are unfounded. The stock currently trades at a relatively low price-to-earnings ratio of 9.7x and offers a free cash flow yield of 8.5%, indicating potential for value. Despite its growth potential in banking and insurance services, experts are suggesting caution as the stock has triggered stop-loss levels and is seen as stagnating. It may be a good time to reassess positions in light of recent performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
WNS, WNS
BUY ON WEAKNESS
Might be a little high. Perfers in the low $20's.
PAST TOP PICK
(Was a top pick on April 10 up 7.5%) A little expensive now but they are still holding.
DON'T BUY
Will be hard to have more growth.
TOP PICK
A leader in all its products. Strong mngmnt.
DON'T BUY
Dominant in razor blades. Not a fan of mngmnt (old thinking?). Concerns on their business model. A one product company.
DON'T BUY
Management has stumbled.
Showing 16 to 21 of 21 entries